Troy Rafferty Secures $19 Million Verdict for Accutane Plaintiffs

In 2012, Troy Rafferty played a key role in securing an $18 million verdict for two plaintiffs, Katie Rossitto and Riley Wilkinson, former users of the acne medication Accutane. 

Both plaintiffs developed ulcerative colitis, a debilitating gastrointestinal disease, as a result of using the drug. The New Jersey jury ruled in favor of the plaintiffs, determining that Hoffman-La Roche, the drug's manufacturer, failed to adequately warn users about the risks of the medication. This case was part of a broader series of lawsuits against Accutane.